MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Li, Qifeng ^a   Shen, Ke ^b   Zhao, Yang ^a   Ma, Chenkai ^a   Liu, Jianwen ^b   Ma, Jie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

DKK3; Glioma; MiR 92b; Prognosis; The Wnt beta catenin signaling pathway

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; GLYCOPROTEIN; LUCIFERASE; MICRORNA; MICRORNA 92B; MICRORNA 92B INHIBITOR; MYC PROTEIN; PROTEIN BCL 2; PROTEIN C JUN; PROTEIN DKK3; UNCLASSIFIED DRUG; WNT PROTEIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER INFILTRATION; CANCER PROGNOSIS; CANCER TISSUE; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DICKKOPF 3 GENE; DRUG TARGETING; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MTT ASSAY; OVERALL SURVIVAL; REPORTER GENE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; APOPTOSIS; BASE SEQUENCE; BETA CATENIN; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; FLOW CYTOMETRY; GLIOMA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84889771949     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-302     Document Type: Article

References (34)

1. Geiger GA. Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system. Cancer Res 2008, 9:3396-3404.
2. Zheng Y. TGF-alpha induces upregulation and nuclear translocation of Hes1 in glioma cell. Cell Biochem Funct 2008, 6:692-700.
3. Eyler CE. Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells 2008, 12:3027-3036.
4. Zhao C. Computational prediction of MicroRNAs targeting GABA receptors and experimental verification of miR-181, miR-216 and miR-203 targets in GABA-A receptor. BMC Res Notes 2012, 5:91. 10.1186/1756-0500-5-91, 3296612, 22321448.
5. Krutzfeldt J. Strategies to determine the biological function of microRNAs. Nat Genet 2006, 38(Suppl):S14-S19.
6. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 2:281-297.
7. Baley J. MicroRNAs and ovarian function. J Ovarian Res 2012, 5:8. 10.1186/1757-2215-5-8, 3305379, 22321819.
8. Liu S. Role of microRNAs in the regulation of breast cancer stem cells. J Mammary Gland Biol Neoplasia 2012, 1:15-21.
9. Karius T. MicroRNAs in cancer management and their modulation by dietary agents. Biochem Pharmacol 2012, 12:1590-1601.
10. Ha TY. MicroRNAs in human diseases: from lung, liver and kidney diseases to infectious disease, sickle cell disease and endometrium disease. Immune Netw 2011, 6:309-323.
11. Zhang Q. Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues. Zhonghua Zhong Liu Za Zhi 2011, 12:885-890.
12. Cho WC. Exploiting the therapeutic potential of microRNAs in human cancer. Expert Opin Ther Targets 2012, 4:345-350.
13. Benetatos LE. DLK1-MEG3 imprinted domain microRNAs in cancer biology. Crit Rev Eukaryot Gene Exp 2012, 1:1-15.
14. Berezikov E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 1:21-24.
15. Lim LP. Vertebrate microRNA genes. Science 2003, 5612:1540.
16. Lewis BP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 1:15-20.
17. Xie X. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 2005, 7031:338-345.
18. Spahn M. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer 2010, 2:394-403.
19. Takamizawa. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 11:3753-3756.
20. Inamura K. let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. Lung Cancer 2007, 3:392-396.
21. Nass D. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 2009, 3:375-383.
22. Haug BH. MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma. Carcinogenesis 2011, 7:1005-1012.
23. Kroemer G. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007, 1:99-163.
24. Liang X. B1, a novel amonafide analogue, overcomes the resistance conferred by Bcl-2 in human promyelocytic leukemia HL60 cells. Mol Cancer Res 2010, 12:1619-1632.
25. Nakamura RE. Analysis of Dickkopf3 interactions with Wnt signaling receptors. Growth Factors 2010, 4:232-242.
26. Ueno K. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma. Mol Carcinog 2011, 6:449-457.
27. Lambiv WL. The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence. Neuro Oncol 2011, 7:736-747.
28. Gotze S. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. Int J Cancer 2010, 11:2584-2593.
29. Utsuki S. Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J Neurooncol 2002, 3:187-192.
30. Gregory RI. MicroRNA biogenesis and cancer. Cancer Res 2005, 9:3509-3512.
31. Sun J. Uncovering MicroRNA and transcription factor mediated regulatory networks in glioblastoma. PLoS Comput Biol 2012, 7:e1002488.
32. Lee EJ. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer 2009, 2:287-297.
33. Sareddy GR. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int 2009, 5:307-317.
34. Wang K. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase. Neuro Oncol 2013, Epub.